Current Technologies for Sub-Micrometer and Micrometer Particle Analysis for Biologics
Posted on June 22,2017
Introduction Analyzing and controlling the particle content in biopharmaceutical drug products is a challenge scientists must face throughout a product’s life cycle starting at early drug research, during drug product development, manufacturing and storage. Particles can hereby originate from the ...
To read the full article and other articles in this issue, please register for an account or log in.
Related Topics and Keywords
Andrea Hawe, biologics, biopharmaceutical drug products, Coriolis Pharma, CQAs, critical quality attributes, Daniel Weinbuch, degraded polysorbate, drug substance, DS, extrinsic particles, light obscuration, LO, micrometer analysis, micrometer particle analysis, nanoparticulate impurities, Narhi, particle content, protein aggregates, sub micrometer, sugar excipients